Gut Bacterial Tyrosine Decarboxylases Restrict Levels of Levodopa in the Treatment of Parkinson’s Disease

Nature Communications - United Kingdom
doi 10.1038/s41467-019-08294-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Effects of Levodopa on Gait in Parkinson’s Disease

New Zealand Journal of Physiotherapy
Physical TherapySports TherapyRehabilitation
2017English

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2012English

Management of Levodopa for Residents With Parkinson’s Disease

Nursing older people
Gerontology
2016English

Levodopa-Carbidopa-Related Rash in Parkinson’s Disease: A Case Series

Canadian Journal of Neurological Sciences
MedicineNeurology
2018English

Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions

Advances in Parkinson's Disease
2017English

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2019English

Alpha Methyldopahydrazine as an Adjunct to Levodopa Therapy in Parkinson’s Disease

Canadian Journal of Neurological Sciences
MedicineNeurology
1975English

Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson’s Disease

Frontiers in Behavioral Neuroscience
Cognitive NeurosciencePhysiological PsychologyBehavioral NeuroscienceNeuropsychology
2017English

Neuropathy in Parkinson’s Disease Patients With Intestinal Levodopa Infusion Versus Oral Drugs

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy